Invention Grant
- Patent Title: Inhibitor of τ protein phosphorylation
-
Application No.: US14769707Application Date: 2014-02-21
-
Publication No.: US09603821B2Publication Date: 2017-03-28
- Inventor: Tomoyuki Nishizaki , Akito Tanaka
- Applicant: NISHIZAKI BIOINFORMATION RESEARCH INSTITUTE
- Applicant Address: JP Kobe
- Assignee: Nishizaki Bioinformation Research Institute
- Current Assignee: Nishizaki Bioinformation Research Institute
- Current Assignee Address: JP Kobe
- Agency: Leydig, Voit & Mayer, Ltd.
- Priority: JP2013-033668 20130222
- International Application: PCT/JP2014/054231 WO 20140221
- International Announcement: WO2014/129598 WO 20140828
- Main IPC: A61K31/20
- IPC: A61K31/20

Abstract:
8-[2-(2-pentyl-cyclopropylmethyl)-cyclopropyl]-octanoic acid has a protein tyrosine phosphatase 1B (PTP1B) inhibitory action, an Akt activating action, a GSK-3β phosphorylation promoting action, and a suppressive action on τ protein phosphorylation induced by Aβ1-42, and is useful as a therapeutic drug for Alzheimer-type dementia, an antidepressant and/or an anti-aging drug.
Public/Granted literature
- US20160008308A1 INHIBITOR OF TAU PROTEIN PHOSPHORYLATION Public/Granted day:2016-01-14
Information query
IPC分类: